CorVel Corp. $CRVL Stock Holdings Increased by Quantinno Capital Management LP

Quantinno Capital Management LP raised its position in shares of CorVel Corp. (NASDAQ:CRVL) by 328.4% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 81,544 shares of the business services provider’s stock after buying an additional 62,508 shares during the quarter. Quantinno Capital Management LP’s holdings in CorVel were worth $4,456,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in CRVL. Northwestern Mutual Wealth Management Co. acquired a new position in shares of CorVel in the 3rd quarter worth approximately $31,000. Los Angeles Capital Management LLC acquired a new stake in shares of CorVel during the 4th quarter valued at approximately $33,000. Eagle Bay Advisors LLC bought a new position in CorVel during the fourth quarter worth $37,000. Rockefeller Capital Management L.P. lifted its stake in CorVel by 66.9% during the fourth quarter. Rockefeller Capital Management L.P. now owns 574 shares of the business services provider’s stock worth $39,000 after purchasing an additional 230 shares during the last quarter. Finally, Quarry LP boosted its holdings in CorVel by 218.6% in the third quarter. Quarry LP now owns 513 shares of the business services provider’s stock worth $40,000 after purchasing an additional 352 shares during the period. Institutional investors and hedge funds own 51.36% of the company’s stock.

Analyst Ratings Changes

Several analysts have weighed in on CRVL shares. Weiss Ratings upgraded shares of CorVel from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 16th. Wall Street Zen upgraded shares of CorVel from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, CorVel currently has a consensus rating of “Hold”.

CorVel Stock Performance

NASDAQ:CRVL opened at $62.56 on Friday. CorVel Corp. has a 1 year low of $44.83 and a 1 year high of $93.71. The stock has a market cap of $3.19 billion, a price-to-earnings ratio of 27.80 and a beta of 0.98. The business has a fifty day moving average of $61.04 and a 200-day moving average of $57.87.

CorVel (NASDAQ:CRVL) last issued its quarterly earnings data on Tuesday, August 4th. The business services provider reported $0.63 earnings per share for the quarter. The business had revenue of $259.93 million for the quarter. CorVel had a net margin of 11.72% and a return on equity of 29.92%.

Insider Buying and Selling at CorVel

In other CorVel news, insider Maxim Shishin sold 2,250 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $60.59, for a total transaction of $136,327.50. Following the sale, the insider directly owned 7,050 shares in the company, valued at approximately $427,159.50. The trade was a 24.19% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Jennifer Yoss sold 1,999 shares of the business’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $61.02, for a total transaction of $121,978.98. Following the sale, the vice president owned 2,173 shares in the company, valued at $132,596.46. This trade represents a 47.91% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 13,249 shares of company stock valued at $807,126. Company insiders own 39.72% of the company’s stock.

CorVel Company Profile

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).